Haptoglobin interacts with Apolipoprotein e and beta-amyloid and influences their crosstalk

ACS Chemical Neuroscience

Volumn 5, Issue 9, 2014, Pages 837-847

  Spagnuolo, Maria Stefania ^a   Maresca, Bernardetta ^b   La Marca, Valeria ^b   Carrizzo, Albino ^c   Veronesi, Carlo ^d   Cupidi, Chiara ^e   Piccoli, Tommaso ^f   Maletta, Raffaele Giovanni ^e   Bruni, Amalia Cecilia ^e   Abrescia, Paolo ^b   Cigliano, Luisa ^b  

^a Natl Res Cncl 80147 Napoli I   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS NEUROMED   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e ASP Catanzaro   (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

Author keywords

Alzheimer' disease; ApoE A complex; Apolipoprotein E; Beta amyloid; Haptoglobin; Human brain tissue

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; HAPTOGLOBIN; AMYLOID PRECURSOR PROTEIN; PROTEIN BINDING;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BINDING COMPETITION; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN TISSUE; CELL LINE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; CHO CELL LINE; CRICETULUS; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEINS E; BRAIN; CHO CELLS; CRICETULUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPTOGLOBINS; HUMANS; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; MUTATION; PROTEIN BINDING; TRANSFECTION;

EID: 84923361440     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn500099f     Document Type: Article

References (49)

1. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
2. Huang, Y., and Mucke, L. (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222.
3. Munson, G. W., Roher, A. E., Kuo, Y. M., Gilligan, S. M., Reardon, C. A., Getz, G. S., and LaDu, M. J. (2000) SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides. Biochemistry 39, 16119-16124.
4. Bentley, N. M., LaDu, M. J., Rajan, C., Getz, G. S., and Reardon, C. A. (2002) Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges. Biochem. J. 366, 273-279.
5. Huang, Y. (2006) Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies. Curr. Opin. Drug Discovery Dev. 9, 627-641.
6. Verghese, P. B., Castellano, J. M., and Holtzman, D. M. (2011) Apolipoprotein E in Alzheimer' s disease and other neurological disorders. Lancet Neurol. 10, 241-252.
7. Mahley, R. W., and Rall, S. C., Jr. (2000) Apolipoprotein E: Far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1, 507-537.
8. Rocchi, A., Pellegrini, S., Siciliano, G., and Murri, L. (2003) Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res. Bull. 61, 1-24.
9. Cigliano, L., Pugliese, C. R., Spagnuolo, M. S., Palumbo, R., and Abrescia, P. (2009) Haptoglobin binds the antiatherogenic protein apolipoprotein E - Impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes. FEBS J. 276, 6158-6171.
10. Yang, F., Haile, D. J., Berger, F. G., Herbert, D. C., Van Beveren, E., and Ghio, A. J. (2003) Haptoglobin reduces lung injury associated with exposure to blood. Am. J. Physiol.: Lung Cell. Mol. Physiol. 284, L402-409.
11. Quaye, I. K. (2008) Haptoglobin, inflammation and disease. Trans. R. Soc. Trop. Med. Hyg. 102, 735-742.
12. Langlois, M. R., and Delanghe, J. R. (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42, 1589-1600.
13. Chamoun, V., Zeman, A., Blennow, K., Fredman, P., Wallin, A., Keir, G., Giovannoni, G., and Thompson, E. J. (2001) Haptoglobin as markers of blood-CSF barrier dysfunction: the findings in normal CSF. J. Neurol. Sci. 182, 117-121.
14. Lee, M. Y., Kim, S. Y., Choi, J. S., Lee, I. H., Choi, Y. S., Jin, J. Y., Park, S. J., Sung, K. W., Chun, M. H., and Kim, I. S. (2002) Upregulation of haptoglobin in reactive astrocytes after transient forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 22, 1176-1180.
15. Borsody, M., Burke, A., Coplin, W., Miller-Lotan, R., and Levy, A. (2006) Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology 66, 634-640.
16. Zhao, X., Song, S., Sun, G., Strong, R., Zhang, J., Grotta, J. C., and Aronowski, J. (2009) Neuroprotective role of haptoglobin after intracerebral hemorrhage. J. Neurosci. 29, 15819-15827.
17. Johnson, G., Brane, D., Block, W., van Kammen, D. P., Gurklis, J., Peters, J. L., Wyatt, R. J., Kirch, D. G., Ghanbari, H. A., and Merril, C. R. (1992) Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia. Appl. Theor. Electrophor. 3, 47-53.
18. Argüelles, S., Venero, J. L., García-Rodriguez, S., Tomas-Camardiel, M., Ayala, A., Cano, J., and Machado, A. (2010) Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease. Neurochem. Int. 57, 227-234.
19. Huang, Y. C., Wu, Y. R., Tseng, M. Y., Chen, Y. C., Hsieh, S. Y., and Chen, C. M. (2011) Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease. PLoS One 6, e15809.
20. Powers, J. M., Schlaepfer, W. W., Willingham, M. C., and Hall, B. J. (1981) An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations. J. Neuropathol. Exp. Neurol. 40, 592-612.
21. Yerbury, J. J., Poon, S., Meehan, S., Thompson, B., Kumita, J. R., Dobson, C. M., and Wilson, M. R. (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 21, 2312-2322.
22. Yerbury, J. J., Kumita, J. R., Meehan, S., Dobson, C. M., and Wilson, M. R. (2009) α2-Macroglobulin and Haptoglobin Suppress Amyloid Formation by Interacting with Prefibrillar Protein Species. J. Biol. Chem. 284, 4246-4254.
23. Cocciolo, A., Di Domenico, F., Coccia, R., Fiorini, A., Cai, J., Pierce, W. M., Mecocci, P., Butterfield, D. A., and Perluigi, M. (2012) Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics. Free Radical Biol. Med. 53, 1868-1876.
24. LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., and Frail, D. E. (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 269, 23403-23406.
25. Portelius, E., Olsson, M., Brinkmalm, G., Ruetschi, U., Mattsson, N., Andreasson, U., Gobom, J., Brinkmalm, A., Holtta, M., Blennow, K., and Zetterberg, H. (2012) Mass spectrometric characterization of amyloid-beta species in the 7PA2 cell model of Alzheimer's disease. J. Alzheimer's Dis. 33, 85-93.
26. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
27. Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270, 9564-9570.
28. Sadrzadeh, S. M., and Bozorgmehr, J. (2004) Haptoglobin phenotypes in health and disorders. Am. J. Clin. Pathol. 121 (Suppl), S97-104.
29. Saeed, S. A., Ahmad, N., and Ahmed, S. (2007) Dual inhibition of cyclooxygenase and lipoxygenase by human haptoglobin: its polymorphism and relation to hemoglobin binding. Biochem. Biophys. Res. Commun. 353, 915-920.
30. Roheim, P. S., Carey, M., Forte, T., and Vega, G. L. (1979) Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. U.S.A. 76, 4646-4649.
31. Vance, J. E., and Hayashi, H. (2010) Formation and function of apolipoprotein E containing lipoproteins in the nervous system. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1801, 806-818.
32. Holtzman, D. M., Herz, J., and Bu, G. (2012) Apolipoprotein e and apolipoprotein e receptors: normal biology and roles in Alzheimer disease. Cold Spring Harbor Perspect. Med. 2, a006312.
33. Herrup, K. (2010) Reimagining Alzheimer's disease-an agebased hypothesis. J. Neurosci. 30, 16755-16762.
34. Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., and Bateman, R. J. (2010) Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330, 1774.
35. Mattila, K. M., Pirttilä, T., Blennow, K., Wallin, A., Viitanen, M., and Frey, H. (1994) Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol. Scand. 89, 192-198.
36. Cordonnier, C., and van der Flier, W. M. (2011) Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain 134, 335-344.
37. Stone, J. (2008) What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary haemorrhages. Med. Hypotheses 71, 347-359.
38. Salvatore, A., Cigliano, L., Carlucci, A., Bucci, E. M., and Abrescia, P. (2009) Haptoglobin binds apolipoprotein E and influences cholesterol esterification in the cerebrospinal fluid. J. Neurochem. 110, 255-263.
39. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., and Roses, A. D. (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 90, 1977-1981.
40. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L.-M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., and Roses, A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 8098-8102.
41. Jordán, J., Galindo, M. F., Miller, R. J., Reardon, C. A., Getz, G. S., and LaDu, M. J. (1998) Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18, 195-204.
42. LaDu, M. J., Reardon, C., Van Eldik, L., Fagan, A. M., Bu, G., Holtzman, D., and Getz, G. S. (2000) Lipoproteins in the central nervous system. Ann. N.Y. Acad. Sci. 903, 167-175.
43. Manelli, A. M., Stine, W. B., Van Eldik, L. J., and LaDu, M. J. (2004) ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. J. Mol. Neurosci. 23, 235-246.
44. Krako, N., Magnifico, M. C., Arese, M., Meli, G., Forte, E., Lecci, A., Manca, A., Giuffrè, A., Mastronicola, D., Sarti, P., and Cattaneo, A. (2013) Characterization of mitochondrial dysfunction in the 7PA2 cell model of Alzheimer's disease. J. Alzheimer's Dis. 37, 747-758.
45. Meli, G., Lecci, A., Manca, A., Krako, N., Albertini, V., Benussi, L., Ghidoni, R., and Cattaneo, A. (2014) Conformational targeting of intracellular Aβ oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum. Nat. Commun. 5, 3867-3884.
46. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
47. Cigliano, L., Spagnuolo, M. S., and Abrescia, P. (2003) Quantitative variations of the isoforms in haptoglobin 1-2 and 2-2 individual phenotypes. Arch. Biochem. Biophys. 416, 227-237.
48. Stine, W. B., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In vitro characterization of conditions for Amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278, 11612-11622.
49. Chen, C.-H., and Albers, J. J. (1982) Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J. Lipid Res. 23, 680-691.